Chris Jenkins
Founder, CEO, Principal Partner
Marala McCallister
Chief Operations Officer
Patrick Conley
Director, IBC Operations
Shaun Tamprateep
IT & Operational Systems Architect
Sarah Attwood
Director, Client Services and Business Development
Jason Keaton
Director of Biosafety, Shield Consulting
Melissa Fink
Director of Institutional Review Board (IRB) Operations
Aswathy Sreedharan
Associate Partner & Gene Therapy Biosafety Officer
Garry Coulson
IBC Chair
Hallie Hoskins
Associate Partner & Gene Therapy Biosafety Officer
Heidi Garson Page
Associate Partner & Gene Therapy Biosafety Officer
Jami Sentissi
Associate Partner & Gene Therapy Biosafety Officer
Katie George
Associate Partner & Gene Therapy Biosafety Officer
Marian Hemmelgarn
Associate Partner & Gene Therapy Biosafety Officer
Marilyn Lamm
IBC Chair
Nick Noriea
Associate Partner & Gene Therapy Biosafety Officer
Sunny Hoffman
Associate Partner & Gene Therapy Biosafety Officer
Wendy Parrish
Associate Partner & Gene Therapy Biosafety Officer
West Weiss
Associate Partner & Gene Therapy Biosafety Officer
Paige Kobermann
Roster and Recruiting Specialist
Diane Brostrom
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Fran Newman
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Sabena Blakeney
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Jean Spezia
Operations Specialist
Rachel DePriest
Accounts Specialist
Amanda Bosco
Human Resources Coordinator/Analyst
Brittany Dyer
Executive Assistant

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.